Purity, identity, and content — tested at accredited partner laboratories and issued to a permanent, independently verifiable record. We sell no product; we only measure.
Recycled, edited, and outright fabricated certificates are the norm in this market. Every Certinum report lives at a permanent, unique link that shows the original result — so a certificate can be confirmed as authentic in seconds, rather than accepted on the strength of an unverifiable copy.
Purity is only the starting point. The failures that matter are the ones a single measurement will miss.
Chromatographic purity as a percentage, with the full trace attached to every report.
Mass-spec confirmation that the compound — and its sequence — is what the label claims.
Actual milligrams delivered versus the stated dose. The most common real-world failure.
Bacterial endotoxin screening — the contamination that purity tests don't see.
Lead, cadmium, arsenic, mercury — trace-metal screening for parenteral-intended material.
Every assay consolidated into a single verifiable certificate.
Every result comes off validated analytical instruments — the same class of equipment used in pharmaceutical quality control.
Chromatographic separation and purity quantification, with the full trace on every report.
Anonymized, logged, and prepared under controlled handling before analysis.
Mass-spectrometry confirmation of the compound and its sequence.
Every sample is analysed on validated instruments, under documented methods, with the full data retained.
Vendor scores built only from real, independent tests — never reviews or paid placement. Sample data shown for illustration.
| Vendor | Compound | Purity | Content | Rating | Tested |
|---|---|---|---|---|---|
| Aster Research | BPC-157 | 99.1% | 5.0 mg | A · 96 | 2026-06-28 |
| Northline Labs | Tirzepatide | 99.4% | 10.2 mg | A · 93 | 2026-06-21 |
| Cascade Peptide | Semaglutide | 99.2% | 3.1 mg | B · 74 | 2026-06-15 |
| Vireo Supply | MOTS-C | 88.6% | 1.9 mg | F · 41 | 2026-06-09 |
The same analytical rigor, applied across the peptide supply chain — from the vendor's bench to the pharmacy's release.
Batch-level purity, identity, and content, with a verifiable certificate that turns transparency into a selling point.
Release-oriented testing — purity, endotoxin, and identity — aligned to USP method references.
Independent third-party documentation to satisfy retailers, marketplaces, and your own quality program.
Confirm what's actually in a vial before you rely on it — purity, identity, and true content.
Give your customers independent, verifiable confirmation of what they are buying — under a certificate that carries your own brand.
Establish what is actually in a vial — purity, identity, and true content — with an independent result that rests on no one's word but the data.
"The objectivity and impartiality you expect from a professional laboratory — built into how we're set up, not asserted in our marketing."
We don't sell peptides. We have nothing to gain from any result going one way or the other.
We hold no equity in, and take no commission from, any vendor we test or rank.
Every certificate is issued to a permanent record that can't be edited after the fact — by a vendor or by us.
"A result is only as good as the method behind it. Every assay runs to a documented procedure, on validated instruments, with the full data retained — so a number can be defended, not just reported."
The same price for any compound — no complexity surcharges, no sales calls. Every sample receives full purity and identity analysis.
Leave your email and we'll send your reference ID, current pricing, and shipping instructions.